Surgery remains the gold standard for both BCC and SCC, but, in recent years, for advanced and metastatic cSCC, systemic treatment options with a curative intent include immune checkpoint inhibitors, epidermal growth factor receptor (EGFR) inhibitors, and chemotherapy/electrochemotherapy; however, this requires a multidisciplinary decision approach. Here, EGFR is linked to skin squamous cell carcinoma.